Having trouble accessing articles? Reset your cache.

AllerT: Additional Phase I/IIa data

Additional data from the double-blind, placebo-controlled, Swiss Phase I/IIa AN003 trial in 18 evaluable patients showed

Read the full 166 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE